Immediate Impact
1 from Science/Nature 54 standout
Citing Papers
Fibrosis in IBD: from pathogenesis to therapeutic targets
2024 Standout
Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease
2024 Standout
Works of Christopher Lepsy being referenced
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Christopher Lepsy | 160 | 63 | 43 | 85 | 76 | 18 | 403 | |
| Seung‐Hyeon Seok | 250 | 53 | 27 | 73 | 19 | 16 | 442 | |
| Piet Swart | 217 | 52 | 15 | 30 | 30 | 17 | 414 | |
| Olof Gissberg | 314 | 58 | 23 | 29 | 22 | 15 | 449 | |
| Jyotika Varshney | 195 | 54 | 14 | 39 | 20 | 25 | 456 | |
| Cheng‐Pang Hsu | 178 | 142 | 18 | 49 | 23 | 21 | 365 | |
| Anke Schnabel | 205 | 49 | 6 | 71 | 81 | 8 | 410 | |
| Vivaswath S. Ayyar | 164 | 95 | 19 | 46 | 12 | 22 | 441 | |
| Randy L. Bell | 269 | 61 | 17 | 17 | 42 | 14 | 410 | |
| Bryan D. Marks | 241 | 82 | 21 | 22 | 24 | 16 | 437 | |
| Kyle W. Anderson | 315 | 38 | 24 | 25 | 96 | 24 | 456 |
All Works
Loading papers...